Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 1 - 50 out of 2,502

Document Document Title
WO/2018/007595A1
The present disclosure relates to a medical dressing comprising a carrier material and a composite material. The composite material comprises oil droplets dispersed in a matrix. The matrix comprises one or more cellulose derivatives and ...  
WO/2018/004739A1
The present invention provides thin-film forming compositions comprising an antiseptic (e.g., povidone iodine, chlorhexidine, or octenidine), a non-aqueous solvent, and a film-forming material dissolved in the non-aqueous solvent, wherei...  
WO/2017/214631A1
Methods for treating a wound with a wound packing are discussed. While the wound packing can include any suitable component, in some cases, it includes a collection of multi-potent cells (e.g., cells from bone marrow, amniotic membrane t...  
WO/2017/210421A1
Hemostatic powders are synergistically used in conjunction with self-assembling peptide hydrogels to promote hemostasis at a target site. Related methods, kits, and devices for hemostasis are disclosed.  
WO/2017/191416A1
The present invention relates to a composition which has a low affinity with respect to latex gloves, comprising a hydrophobic matrix, characterized in that said hydrophobic matrix comprises: - for 100 parts by weight of a mixture P of 2...  
WO/2017/186168A1
A medical hydrogel composition, a medical hydrogel, a preparation method therefore and an application thereof, and a medical hydrogel kit. The medical hydrogel composition comprises a first component and a second component; the first com...  
WO/2017/174874A1
One embodiment provides a method for preparing a medical product, said method comprising providing an aqueous dispersion of nanofibrillar cellulose, providing a layer of gauze, impregnating the layer of gauze with the aqueous dispersion ...  
WO/2017/177225A1
An immune-modulating biomaterial comprising a hydrogel scaffold coupled to D-amino acid containing peptides having unexpected properties in vivo is described. For example, certain inflammatory reactions in vivo are significantly increase...  
WO/2017/163603A1
The present invention provides a composition for replenishing the nucleus pulposus of an intervertebral disc, the composition containing a monovalent metal salt of a low endotoxin alginic acid. The composition is applied to a nucleus pul...  
WO/2017/158250A1
The invention relates to the field of silicone gels that are adhesive to the skin, able to be used in particular for articles that are adhesive to the skin for medical or paramedical use.  
WO/2017/158249A1
The invention relates to the field of silicone gels that are adhesive to the skin, able to be used in particular for articles that are adhesive to the skin for medical or paramedical use.  
WO/2017/139514A1
Compositions, methods and apparatuses for phototherapy to treat skin disorders. In particular, described herein are methods, compositions, phototherapy dressings for use with phototherapy UV light applicators (sources) and phototherapy U...  
WO/2017/127717A1
A biocompatible analyte sensing material for intradermal or subcutaneous application includes a collection of microgel particles having one or more network crosslinker components and an endogenous or exogenous annealing agent that links ...  
WO/2017/127452A1
A formulation is disclosed for use in wound healing. The formulation may include hvpochlorous acid, a silicone polymer or blend thereof, sodium phosphate, hydrochloric acid, and sodium magnesium silicate. Methods of using and making the ...  
WO/2017/125687A1
The present invention relates to a novel cryogenic composition intended to be used in heat treatment devices, and to the method of preparing same. The invention also relates to a heat treatment device and, more particularly, to a medical...  
WO/2017/117995A1
A chitosan-containing fibrin glue and use method thereof. The chitosan-containing fibrin glue comprises first lyophilized powder and second lyophilized powder, wherein components of the first lyophilized powder comprise fibrinogen, facto...  
WO/2017/117996A1
A biological product for surgical hemostasis and use method thereof. The biological product for surgical hemostasis comprises first lyophilized powder and second lyophilized powder, wherein components of the first lyophilized powder comp...  
WO/2017/108770A1
The invention relates to a wound treatment system which can be particularly advantageously used, in particular, in wound treatment during the epithelisation phase. The wound treatment system comprises a carrier layer and at least two hyd...  
WO/2017/104723A1
[Problem] To provide a composition for hemostasis that can be applied uniformly to a bleeding site and exerts a high hemostatic effect. [Solution] Provided is a composition to be applied to the subject as a spray, wherein the composition...  
WO/2017/106573A1
A medical adhesive that bonds well to human tissue while curing in a fast, controllable manner. In a preferred form, the medical adhesive includes an oligomer, a hydrogel and/or water soluble polymer and a photoinitiator. Preferred oligo...  
WO/2017/100600A3
Methods and systems for stiffening of tissue are presented to allow improved processing. Solutions comprising an acid or a base can be contacted with tissue to stiffen one or more components of the tissue. The resulting stiffened tissue ...  
WO/2017/089831A1
The present invention relates to skin dressings that are useful in the treatment of conditions associated with tissue ischaemia and skin lesions including those that are infected, such as burns and surgical wounds and chronic wounds such...  
WO/2017/089465A1
A nutritional supplement formulation is provided, which contains a wound healing substance for use in the pre- and/or post-treatment of tattooing, for use in improving the coloring and/or color saturation of the tattoo and/or for use in ...  
WO/2017/085705A1
An acellular product may be derived from human placenta and may be used in various scenarios for wound healing. Because the product may be acellular, the product may be processed for storage and transportation with minimal degradation. T...  
WO/2017/083398A1
Disclosed herein are compositions that can form a covering, layer, film, device, and/or prosthetic skin that can be comfortably worn to provide skin barrier function, skin hydration and therapeutic and aesthetic benefits. The present inv...  
WO/2017/083248A1
The present invention relates to a sealant formulation comprising a blend containing fibrinogen and an exogenous activator of a member of a mammalian blood clotting cascade.  
WO/2017/081259A1
The invention provides a dry biocompatible film comprising at least one film forming material and particulate egg shell membrane (ESM), wherein said particulate ESM is distributed substantially uniformly in and/or on the film and wherein...  
WO/2017/076782A1
The present disclosure relates to a composition of an engineered biomaterial including extracellular matrix components of a mammalian tissue and a polymer; method of wound healing;and methods delivering therapeutic agents, growth factors...  
WO/2017/069080A1
The present invention relates to preventing the color transfer and adhesion of a powder-containing cosmetic onto clothing. This method for producing a coating film involves an electrostatic spray step for forming a coating film on the sk...  
WO/2017/070017A1
The present invention generally relates to a topical composition including loperamide and a pharmaceutically acceptable carrier and to a method of using such a composition. One embodiment of the method provides for analgesia or antihyper...  
WO/2017/069079A1
A method for producing a coating film is provided which has high adhesion between the skin and the coating film formed by an electrostatic spray. This method for producing a coating film involves a solution application step for applying ...  
WO/2017/066605A1
The application relates to the healing of wounds. Provided herein are methods directed to treatment of hard-to-heal or chronic wounds by sequential administration of M1 and M2 macrophages to the wound site.  
WO/2017/060821A1
What is claimed is a local hemostatic composition which aims to increase blood stopping efficiency, and provides the possibility of transporting the wounded after formation of artificial thrombus, allows movement of the wounded without r...  
WO/2017/058698A1
Described herein is a multilayer article comprising: a. a polymer substrate comprising an abstractable atom; and b. a hydrogel coating thereon wherein the hydrogel coating has a water content of at least 10 wt% and is covalently bonded t...  
WO/2017/055135A1
A stabilised antiseptic preparation comprises at least one vitamin, and/or at least one metal ion, and/or at least one surface-active compound, and/or at least one gellant, and/or at least one antimicrobial agent from the group of quater...  
WO/2017/051433A1
The present invention discloses a biodegradable and biocompatible pharmaceutical composition comprising silk Sericin, sophorolipid, a gelling or thickening agent and one or more pharmaceutically acceptable carriers or excipients for fast...  
WO/2017/032790A1
The present invention relates to a silicone foam that is produced in situat a wound site, e.g. in a wound cavity, through a multi-component system, based on a physical foaming process, wherein the gas required to form the foam structure ...  
WO/2017/032614A1
The present invention relates to in vitro cultured senescent cells, such as epithelial cells, keratinocytes and/or fibroblasts as well as their use in the treatment of tissue regeneration, particularly for the treatment of wounds such as...  
WO/2017/027253A1
A method of inhibiting bleeding from an open surgical site includes mixing (i) a flowable gel solution comprising a biopolymer dissolved in a first solvent and (ii) a flowable hardener solution comprising a cross-linking agent dissolved ...  
WO/2017/015703A1
According to the present invention there is provided a polymer comprising at least one antiseptic/analgesic/anti-inflammatory monomeric unit in conjunction with at least three further monomeric units, said three further monomeric units e...  
WO/2017/011050A3
Disclosed herein is a multilayered wound dressing comprising a first layer; the first layer including channels that facilitate neovascularization of a wound; and a second layer in contact with the first layer, the second layer having the...  
WO/2016/210112A1
Methods, compositions, kits, and drug delivery devices are provided for treating, adhering, or sealing biological tissues. The methods include combining a first solution that includes an oligomer/polymer component and a second solution t...  
WO/2016/202984A1
A composition with improved adhesive and sealant properties comprises a) a pre-polymer comprising a polymeric unit of the general formula (-A-B-)n, wherein A represents a substituted or un-substituted ester, B represents a substituted or...  
WO/2016/190400A1
A hydrogel which adheres to surfaces of materials is provided by using, as constituent elements, a water-soluble main-chain monomer, a crosslinking agent, a polymerization initiator, and an adhesive monomer having at least a catechol gro...  
WO/2016/189266A1
A sterilized sachet (1) comprises a sealed impervious pouch (2) containing a biocide (4). The pouch (2) but not the biocide (4) has been sterilized by irradiation prior to having been filled with the biocide (4) and sealed. Preferably, t...  
WO/2016/185214A1
The invention provides a device for application to the skin of a patient to facilitate intravenous access, e.g. via needles, syringes, cannulas or catheters, the device having an upper surface and a lower surface, wherein the lower surfa...  
WO/2016/181137A1
A sterile, ready-to-use, flowable haemostatic composition comprises a soluble haemostatic agent comprising a plurality of carriers and a plurality of fibrinogen binding peptides immobilised to the carrier; a biocompatible liquid; and par...  
WO/2016/178829A1
Provided is a chitosan based hemostatic formulation comprising carboxymethyi chitosan, and methyl cellulose. More particularly, provided is a chitosan based hemostatic formulation comprising carboxymethyi. chitosan, methyl cellulose, hyd...  
WO/2016/174104A1
The present invention relates to bacterial nanocellulose composite which comprises nanocellulose, sensor or signal processing molecule(s), actuator/effector molecule(s) and/or cells and optionally further component(s). The present invent...  
WO/2016/176186A1
A hemostatic composition comprises calcium alginate, a chitosan, epsilon-aminocaproic acid, an acid selected from aminomethylbenzoic acid and tranexamic acid, and tannin. The method of making the hemostatic composition comprises mixing o...  

Matches 1 - 50 out of 2,502